Interpreting SPRINT: How low should you go?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26974989.
- Also identified by DOI 10.3949/ccjm.83a.15175.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Systolic Blood Pressure Intervention Trial (SPRINT) found evidence of cardiovascular benefit with intensive lowering of systolic blood pressure (goal < 120 mm Hg) compared with the currently recommended goal (< 140 mm Hg) in older patients with cardiovascular risk but without diabetes or stroke. This article reviews the trial design and protocol, summarizes the results, and briefly discusses the implications of these results.
Medical subject headings
- Antihypertensive Agents
- Blood Pressure
- Hypertension
- Randomized Controlled Trials as Topic